1. Home
  2. IPSC vs ATLX Comparison

IPSC vs ATLX Comparison

Compare IPSC & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • ATLX
  • Stock Information
  • Founded
  • IPSC 2019
  • ATLX 2011
  • Country
  • IPSC United States
  • ATLX Brazil
  • Employees
  • IPSC N/A
  • ATLX N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • IPSC Health Care
  • ATLX Industrials
  • Exchange
  • IPSC Nasdaq
  • ATLX Nasdaq
  • Market Cap
  • IPSC 149.1M
  • ATLX 156.3M
  • IPO Year
  • IPSC 2021
  • ATLX N/A
  • Fundamental
  • Price
  • IPSC $1.26
  • ATLX $7.72
  • Analyst Decision
  • IPSC Strong Buy
  • ATLX Strong Buy
  • Analyst Count
  • IPSC 4
  • ATLX 3
  • Target Price
  • IPSC $13.00
  • ATLX $33.17
  • AVG Volume (30 Days)
  • IPSC 485.3K
  • ATLX 129.3K
  • Earning Date
  • IPSC 11-05-2024
  • ATLX 11-08-2024
  • Dividend Yield
  • IPSC N/A
  • ATLX N/A
  • EPS Growth
  • IPSC N/A
  • ATLX N/A
  • EPS
  • IPSC N/A
  • ATLX N/A
  • Revenue
  • IPSC $2,684,000.00
  • ATLX $543,657.00
  • Revenue This Year
  • IPSC $244.52
  • ATLX N/A
  • Revenue Next Year
  • IPSC $27.73
  • ATLX $8,970.97
  • P/E Ratio
  • IPSC N/A
  • ATLX N/A
  • Revenue Growth
  • IPSC 7.88
  • ATLX 87586.61
  • 52 Week Low
  • IPSC $1.14
  • ATLX $6.25
  • 52 Week High
  • IPSC $5.51
  • ATLX $34.00
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 41.15
  • ATLX 44.32
  • Support Level
  • IPSC $1.20
  • ATLX $7.47
  • Resistance Level
  • IPSC $1.50
  • ATLX $8.25
  • Average True Range (ATR)
  • IPSC 0.13
  • ATLX 0.73
  • MACD
  • IPSC -0.00
  • ATLX -0.14
  • Stochastic Oscillator
  • IPSC 24.45
  • ATLX 16.55

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

Share on Social Networks: